Do Novel Nonexercise and Nondrug Treatments Improve Global Cognition in Parkinson's Disease Patients? A Systematic Review and Bayesian Analysis
European Journal of Neuroscience · 2025
DOI: 10.1111/ejn.70008 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift European Journal of Neuroscience, 2025. Verfasst von Yingle Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern M…. Hauptthemen laut MEDLINE: Cognition, Cognitive Behavioral Therapy, Cognitive Dysfunction, Parkinson Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Science and Technology Planning Project of Guangzhou, National Natural Science Foundation of China.
Abstract (Originalsprache)
This Bayesian network meta‐analysis method was used to assess the effect of novel treatments on global cognition in patients with Parkinson's disease (PD). We searched randomized controlled trials from PubMed, Cochrane Library, Web of Science and Embase to investigate novel treatments for global PD cognition until April 10, 2024. Effect size measures were standardized mean differences with 95% confidence intervals. We included 13 studies investigating traditional paper‐and‐pencil cognitive training, modified cognitive training (MCT), repetitive transcranial magnetic stimulation (rTMS), rTMS plus MCT, Mediterranean diet, speech therapy, transcranial direct current stimulation (tDCS) and tDCS plus MCT. Comparisons between novel treatments and the control group revealed the following findings: Mediterranean diet (1.25, 0.74–1.76), rTMS plus MCT (0.82, 0.13–1.52), rTMS (0.42, 0.08–0.76) and MCT (0.34, 0.03–0.66) exhibited statistically significant improvements in global cognition in patients with PD, while the remaining treatments did not reveal significant differences. To conclude, the Mediterranean diet, rTMS, MCTs and rTMS plus MCT could effectively improve global cognition in patients with PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Guangdong Neuroscience Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Guangzhou key Laboratory of Diagnosis and Treatment for Neurodegenerative Diseases, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
ORCID-Profile: Yingle Tang
Förderung
- Science and Technology Planning Project of Guangzhou
- National Natural Science Foundation of China
Zitieren
APA
Tang, Y., He, P., Li, Y., Ma, G., Zhang, Y., Wang, L., & Nie, K. (2025). Do Novel Nonexercise and Nondrug Treatments Improve Global Cognition in Parkinson's Disease Patients? A Systematic Review and Bayesian Analysis. European Journal of Neuroscience. https://doi.org/10.1111/ejn.70008
Vancouver
Tang Y, He P, Li Y, Ma G, Zhang Y, Wang L, et al. Do Novel Nonexercise and Nondrug Treatments Improve Global Cognition in Parkinson's Disease Patients? A Systematic Review and Bayesian Analysis. European Journal of Neuroscience. 2025. doi:10.1111/ejn.70008
BibTeX
@article{Tang2025,
author = {Tang, Yingle and He, Peikun and Li, Yanyi and Ma, Guixian and Zhang, Yuhu and Wang, Lijuan and Nie, Kun},
title = {Do Novel Nonexercise and Nondrug Treatments Improve Global Cognition in Parkinson's Disease Patients? A Systematic Review and Bayesian Analysis},
journal = {European Journal of Neuroscience},
year = {2025},
doi = {10.1111/ejn.70008}
}
EUVIMED